Cephalogics Announces Launch Order for Its Neuroimaging System
07-Jul-2009
Boston, Massachusetts - Cephalogics LLC announced today the company’s first sale of its high-density, diffuse optical imaging system to a leading US university. The principal investigator (PI) is an expert in tissue optics and optical medical imaging, and has used these techniques to study functional brain activities, as well as for tumor diagnosis and prognosis under a variety of treatments. “Although the PI already has multiple neuroimaging machines, we are confident that our system will produce a high level of data quality unseen in other optical imaging systems,” said Marc Eichenberger, Chief Operating Officer of Allied Minds, parent of Cephalogics.
Cephalogics makes non-invasive, portable optical brain imaging systems that produce a more complete picture of brain function in real-time to guide treatment of neurological diseases. Among other features, this first order will include 24 source-detector pairs, real-time decoding on data collection, an optimized fiber bundle and a control PC.
About Cephalogics, LLC and Allied Minds, Inc.
Cephalogics, LLC is a privately-held startup company formed by Allied Minds, Inc. to commercialize the high-density diffuse optical tomography (HD-DOT) neuroimaging technology originally developed at Washington University in St. Louis by Dr. Joseph Culver. For more information, please visit the Cephalogics website: www.cephalogics.com. Allied Minds, Inc. is the premier seed organization for early-stage technology. The company focuses on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, the company fosters early-stage companies through to success, generating value for all stakeholders. Allied Minds has a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom. For more information, please visit www.alliedminds.com
Cephalogics makes non-invasive, portable optical brain imaging systems that produce a more complete picture of brain function in real-time to guide treatment of neurological diseases. Among other features, this first order will include 24 source-detector pairs, real-time decoding on data collection, an optimized fiber bundle and a control PC.
About Cephalogics, LLC and Allied Minds, Inc.
Cephalogics, LLC is a privately-held startup company formed by Allied Minds, Inc. to commercialize the high-density diffuse optical tomography (HD-DOT) neuroimaging technology originally developed at Washington University in St. Louis by Dr. Joseph Culver. For more information, please visit the Cephalogics website: www.cephalogics.com. Allied Minds, Inc. is the premier seed organization for early-stage technology. The company focuses on converting academic discoveries into commercial reality by working exclusively with a network of U.S. universities and national labs. By filling the gap between government grants and traditional venture capitalists, Allied Minds focuses on funding innovations with significant transformative potential. Instead of managing funds, the company fosters early-stage companies through to success, generating value for all stakeholders. Allied Minds has a nationwide footprint with offices in Boston, Seattle, Washington, D.C. and Los Angeles, and a European presence in London, United Kingdom. For more information, please visit www.alliedminds.com
